FDA Launches “Remove the Risk” Campaign for Safe Disposal of Unused Opioids
The U.S. Food and Drug Administration is launching on April 25, 2019, its “Remove the Risk” campaign, aimed at promoting the safe disposal of unused opioids.
Policy
Terminally Ill People in New Jersey Given Right to End Lives
The new law takes effect on August 1 and allows adults with a prognosis of six months or less to live to get a prescription for life-ending, self-administered pills that can be taken at home.
Head of National Cancer Institute Named Acting FDA Commissioner
Current commissioner, Scott Gottlieb, will be stepping down in April
FDA Down to 5 Weeks of Funding to Review New Drug Applications
Due to the federal government shutdown, the US Food and Drug Administration has only about 5 weeks of funding left to review new drug applications.
Protecting Your Practice From Data Breaches: An Expert Interview
To shed light on issues of cybersecurity in medical practices, MPR spoke to Michael J Sacopulos, JD, CEO of Medical Risk Institute (MRI), a firm that provides “proactive counsel” to the healthcare community to identify where liability risks originate and to reduce or remove those risks.
FDA: Food Inspections to Resume Despite Ongoing Funding Lapse
The news comes after FDA Commissioner Scott Gottlieb, MD announced last week a plan to recall some furloughed workers to conduct inspections.
American College of Physicians Releases 7th Edition of Ethics Manual
Manual focuses on patient-physician relationship in different scenarios, including telemedicine
How the Government Shutdown Affects FDA Activities
The consequence of the shutdown means the budget appropriated by Congress for the Agency is on hold, resulting in ~7000 of it’s 17,000 employees being furloughed.
Health Officers Express Concerns About Vaccine Exemptions
With new California law eliminating nonmedical exemptions, rise in medical exemptions reported
DEA Proposal Will Significantly Cut Opioid Manufacturing in 2019
Last year, the DEA proposed a 20% reduction in the manufacturing of controlled substances for 2018 compared to 2017.
